INSM (STOCKS)
Insmed, Inc.
$146.030000
-2.400000 (-1.62%)
Prev close: $148.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William H. Lewis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $31,180.58M
- Employees
- 1,271
- P/E (TTM)
- -23.65
- P/B (TTM)
- 32.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
16
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.75 | $-1.37 | -0.3838 | -28.09% |
|
Jun 2025 (Q2)
|
$-1.70 | $-1.32 | -0.3808 | -28.87% |
|
Mar 2025 (Q1)
|
$-1.42 | $-1.36 | -0.0607 | -4.47% |
|
Dec 2024 (Q4)
|
$-1.32 | $-1.19 | -0.1329 | -11.20% |
Financial Statements
| Revenues | $447.02M |
| Benefits Costs and Expenses | $1.63B |
| Cost Of Revenue | $104.87M |
| Costs And Expenses | $1.60B |
| Gross Profit | $342.15M |
| Operating Expenses | $1.50B |
| Selling, General, and Administrative Expenses | $631.20M |
| Research and Development | $695.91M |
| Other Operating Expenses | $172.48M |
| Operating Income/Loss | -$1.16B |
| Income/Loss From Continuing Operations After Tax | -$1.18B |
| Income/Loss From Continuing Operations Before Tax | -$1.18B |
| Income Tax Expense/Benefit | $4.74M |
| Income Tax Expense/Benefit, Deferred | -$29.00K |
| Net Income/Loss | -$1.18B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.18B |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.18B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.19 |
| Diluted Earnings Per Share | -$6.19 |
| Basic Average Shares | 199,117,000 |
| Diluted Average Shares | 199,117,000 |
| Assets | $2.36B |
| Current Assets | $1.93B |
| Inventory | $120.97M |
| Other Current Assets | $1.81B |
| Noncurrent Assets | $428.93M |
| Fixed Assets | $89.67M |
| Other Non-current Assets | $339.26M |
| Liabilities | $1.42B |
| Current Liabilities | $417.21M |
| Accounts Payable | $79.59M |
| Wages | $69.71M |
| Other Current Liabilities | $267.91M |
| Noncurrent Liabilities | $997.95M |
| Long-term Debt | $546.77M |
| Other Non-current Liabilities | $451.18M |
| Equity | $945.57M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $945.57M |
| Liabilities And Equity | $2.36B |
| Net Cash Flow From Operating Activities | -$883.40M |
| Net Cash Flow From Operating Activities, Continuing | -$883.40M |
| Net Cash Flow From Investing Activities | -$322.23M |
| Net Cash Flow From Investing Activities, Continuing | -$322.23M |
| Net Cash Flow From Financing Activities | $1.08B |
| Net Cash Flow From Financing Activities, Continuing | $1.08B |
| Exchange Gains/Losses | -$581.00K |
| Net Cash Flow | -$126.69M |
| Net Cash Flow, Continuing | -$126.11M |
| Comprehensive Income/Loss | -$1.18B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.18B |
| Other Comprehensive Income/Loss | -$1.18B |
| Other Comprehensive Income/Loss Attributable To Parent | $1.45M |